Table 1.

Baseline clinical characteristics of study population.

Clinical features		N
Age		64 (50-78)
Gender	Male	12
	Female	0
Smoking	Active	3
	Less than 5 Pack Years	3
	Never	6
Prior lines of therapy in R/M setting	Naive	4
	1	6
	2	2
Prior PD-1 therapy in R/M setting	Yes	2
	No	10
PD-L1 CPS status	<1%	3
	1-20%	4
	>20%	2
	Not evaluable	3
Recurrence	Metastatic	6
	Locoregional	6